7072 Some studies have found that patients with neurodegenerative diseases, like Parkinsons disease, Alzheimers disease, and amyotrophic lateral sclerosis (ALS), tend to have lower serum uric acid levels, suggesting a potential neuroprotective effect of uric acid
Colombo C, Palumbo G, He JZ, Pinton R, Cesco S
The standard protocol involves 5 to 10 mg daily via subcutaneous injection for 10 to 20 consecutive days, repeated once or twice per year with 4 to 6 months between cycles
The work presented in this paper is unrelated to this funding
It leads to infectious mononucleosis and may play a role in the development of Burkitt lymphoma, some nasopharyngeal carcinomas, and a few rare genetic lymphoproliferative disorders